Avedro, Inc.
http://avedro.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Avedro, Inc.
Deal Watch: Aevi Options AstraZeneca Antibody For Rare Disease
Aevi needs to raise funds first, but hopes to develop MEDI2338 for adult-onset Still’s disease. Also, Alnylam plans to leverage Ironwood’s GI expertise for givosiran in acute hepatic porphyria and Ultragenyx snags option to buy GeneTx.
Execs On The Move, August 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Execs On The Move, July 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
VC Deals Analysis: Variety In Volume, But Lackluster Value In April
It would have been difficult to beat March's unusual bumper harvest, which benefitted from Grail's near-$1bn round, but venture fundraising efforts in April were stymied by the absence of deals beyond the $50m mark.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Topical Delivery
-
Drug Delivery
-
Medical Devices
- Diagnostic Equipment & Supplies
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive